Keyphrases
Age-related Macular Degeneration
67%
Retinal Vein Occlusion
67%
Best-corrected Visual Acuity
55%
Diabetic Macular Edema
44%
Ocular Inflammation
44%
Macular Edema
44%
Ozurdex
44%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
38%
Myopic Choroidal Neovascularization (mCNV)
37%
Vascular Endothelial Growth Factor
35%
Anti-vascular Endothelial Growth Factor Therapy
33%
Neovascular Age-related Macular Degeneration (nAMD)
31%
Visual Acuity
31%
Central Subfield Thickness
28%
Genetic Testing
28%
Treatment Burden
26%
Anti-VEGF Therapy
25%
Prospective Randomized Trial
25%
Atrophy
24%
Choroidal
22%
Dilated Fundus Examination
22%
Angiogenic Factors
22%
Self-identification
22%
Monoclonal Gammopathy of Undetermined Significance
22%
Masquerade
22%
Retinal Diseases
22%
Individual Self
22%
Network Meta-analysis
22%
Angiopoietin-like
22%
Surgical Approach
22%
Randomized pilot Trial
22%
Scatter Photocoagulation
22%
Epithelial Cyst
22%
Visual-evoked Potential Latency
22%
Trans-acting Regulator
22%
Novel Therapeutic Targets
22%
Pathologic Myopia
22%
Proliferative Diabetic Retinopathy
22%
Central Serous Chorioretinopathy
22%
Current Therapies
22%
Dietary Supplements
22%
Patient Use
22%
Copper Deposition
22%
Home Monitoring
22%
Retreatment
22%
Predictive Factors
22%
Ranibizumab
22%
Subfoveal Hemorrhage
22%
Visual Evoked Potentials
22%
Intravitreal
22%
Medicine and Dentistry
Vasculotropin
77%
Age Related Macular Degeneration
67%
Visual Acuity
65%
Wet Macular Degeneration
60%
Central Serous Retinopathy
44%
Network Meta-Analysis
44%
Retina Vein Occlusion
44%
Choroidal Neovascularization
40%
Genetic Screening
28%
Retinal Detachment
28%
Endothelial Cell Growth Factor
27%
Optical Coherence Tomography
26%
Vitreous
25%
Monoclonal Gammopathy of Undetermined Significance
22%
Surgical Approach
22%
Dilated Fundus Examination
22%
Retreatment
22%
Congenital Malformation
22%
Pathologic Myopia
22%
Pediatrics
22%
Nerve Fiber
22%
Home Monitoring
22%
Faricimab
22%
Arteritic Anterior Ischemic Optic Neuropathy
22%
Bleeding
22%
Subretinal Fluid
22%
Macular Degeneration
22%
Ischemic Optic Neuropathy
22%
Predictive Factor
22%
Dietary Supplement
22%
Retinal Vein Occlusion
22%
Scleral Buckle
22%
Macular Edema
22%
Visual Field
22%
Kearns-Sayer Syndrome
22%
Cataract Surgery
19%
Visual Field Test
18%
Best Corrected Visual Acuity
18%
Central Retinal Vein Occlusion
17%
Anterior Chamber of Eyeball
16%
Retinal Imaging
15%
Pars Plana Vitrectomy
15%
Eye Disease
14%
Intraocular Lens
14%
Magnetic Resonance Imaging
13%
Symptom
13%
Glaucoma
11%
Sequela
11%
Axon
11%
Retinopathy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Retina Vein Occlusion
67%
Ranibizumab
46%
Diabetic Macular Edema
44%
Macular Edema
44%
Age Related Macular Degeneration
44%
Edema
29%
Dietary Supplement
22%
Eye Disease
22%
Proliferative Diabetic Retinopathy
22%
Central Serous Retinopathy
22%
Glaucoma
22%
Angiopoietin
22%
Wet Macular Degeneration
22%
Neovascular Glaucoma
22%
Subretinal Neovascularization
22%
Angiogenic Factor
22%
Dexamethasone
22%
Bleeding
22%
Visual Impairment
14%
Prevalence
13%
Carbonate Dehydratase Inhibitor
12%
Beta Adrenergic Receptor Blocking Agent
12%
Clinical Trial
9%
Visual Pigment
8%
Disease
7%
Branch Retinal Vein Occlusion
7%
Central Retina Vein Occlusion
7%
Photodynamic Therapy
6%
Endothelial Cell Growth Factor
6%
Implant
6%
Angiopoietin 2
6%
Scatter Factor
6%
R-Factor
6%
Persephin
6%
Biological Product
5%
Alpha Adrenergic Receptor Stimulating Agent
5%
International Classification of Diseases
5%
Combination Therapy
5%
